ВЛИЯНИЕ СИСТЕМНОЙ ЭНЗИМОТЕРАПИИ НА КЛИНИЧЕСКИЕ И ГЕМОРЕОЛОГИЧЕСКИЕ ПОКАЗАТЕЛИ У БОЛЬНЫХ ИБС: СТЕНОКАРДИЕЙ НАПРЯЖЕНИЯ

• DOI: 10.15829/1560-4071-2005-3-53-57
• Publication Date: 2005-06-28
• Authors: А. Ю. Коняхин; А. Э. Радзевич; Г. В. Аркадьева; Natallia Shmeleva; Т. Р. Каменева; Eugenia Antonova
• Keywords: Hemorheology

This study is devoted to systemic enzyme therapy (wobenzym and phlogenzym) influence on hemostasis, hemorheology, clinical course of disease inpatients (n=54) with Functional Class II-III effort angina, receiving complex therapy. Systemic improved blood rheology due decreased red white cell aggregation, increased elasticity membrane; optimized fibrinolysis hemocoagulation systems' status; angina quality life. Including wobenzym phlogenzym into ofFC patients clinically rational, effective, safe.